Autologous Platelet-Rich Plasma Eye Drops for the Treatment of Post-LASIK Chronic Ocular Surface Syndrome.

Jorge L AlióAlejandra E RodriguezAhmed A AbdelghanyRenan F Oliveira

Published in: Journal of ophthalmology (2017)

Monotherapy with autologous platelet-rich plasma eye drops has been shown to be an adequate option for the treatment of post-LASIK chronic ocular surface syndrome. This trial is registered with NCT03322917.

Keyphrases

platelet rich plasma
combination therapy
clinical trial
bone marrow
case report
stem cells
cell therapy
randomized controlled trial
mesenchymal stem cells